Stock Quote
Watson Pharmaceuticals, Inc. (WPI.N) (New York Stock Exchange)
$36.96
27 Nov 2009
-2.25%
$37.81
$37.00
167,600
$37.30
$36.83
$38.48
$22.16
0.60
895,475
WPI.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Turner, Andrew | Non-Executive Chairman of the Board | -- |
| Bisaro, Paul | President, Chief Executive Officer, Director | 3,772,360 |
| Joyce, R. Todd | Chief Financial Officer, Senior Vice President | -- |
Profile
Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates and manages its business as three operating segments: Generic, Brand and... Full Description
Company Address
Watson Pharmaceuticals, Inc.
311 Bonnie Circle
Corona CA 92880
P: +1951.4935300
F: +1951.2701096
311 Bonnie Circle
Corona CA 92880
P: +1951.4935300
F: +1951.2701096
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Teva Pharmaceutical Industries Limited | ₪20,040.00 | +40.00 |
| Mylan Inc. | $18.01 | -0.28 |
| Covidien PLC | $46.96 | -0.39 |
| WPI.N | Industry | |
|---|---|---|
| P/E(TTM) | 19.04 | 3.68 |
| P/S(TTM) | 1.48 | 0.56 |
| ROI(TTM) | 6.58 | 1.88 |
| ROE(TTM) | 10.16 | 2.54 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | 0.75 |
| EPS Est. (Current Year) | 2.57 |
| Total Revenue | $662.10M |
| Net Income | $63.00M |
| EPS | $0.55 |
